Search

Your search keyword '"Labidi, M."' showing total 17 results
Start Over Author "Labidi, M." Language french
17 results on '"Labidi, M."'

14. [Gastric and pancreatic cancers: Will neoadjuvant (chemo)radiotherapy replace adjuvant chemoradiotherapy?]

Author

Huguet F, Rivin Del Campo E, Labidi M, Ménard J, Sergent G, Durand B, and Quéro L

Subjects
Humans, Adenocarcinoma therapy, Chemoradiotherapy, Adjuvant, Neoadjuvant Therapy, Pancreatic Neoplasms therapy, Stomach Neoplasms therapy
Abstract

For many years, adjuvant chemoradiotherapy remained essential in the therapeutic management of gastric and pancreatic adenocarcinomas. For these tumours, surgical excision, the only hope of offering the patient prolonged survival, is only possible in 20% of cases. The median survival of operated patients is only 12 to 20 months due to the frequency of locoregional and/or metastatic recurrences. For stomach cancers, adjuvant chemoradiotherapy is justified by the results of the phase III trial Intergroup 0116 published by MacDonald et al. The gain in survival was at the cost of significant toxicity. This treatment was supplanted in the early 2000s by perioperative chemotherapy. Currently, neoadjuvant chemoradiotherapy clinical studies are ongoing with the aim of improving treatments observance and tolerance. For pancreatic cancers, the role of adjuvant chemoradiotherapy has long been discussed because of trials with contradictory results. Neoadjuvant radiotherapy has many advantages in terms of efficacy and tolerance. It increases the chances of subsequent complete tumour resection. Several prospective trials are currently ongoing to clarify its place in the therapeutic arsenal., (Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.)

Published
2020
Full Text
View/download PDF

15. [Follow-up after rectal cancer treatment].

Author

Quéro L, Guillerm S, Castelnau-Marchand P, Labidi M, and Hennequin C

Subjects
Clinical Trials, Phase III as Topic, Female, Follow-Up Studies, Humans, Male, Randomized Controlled Trials as Topic, Aftercare methods, Neoplasm Recurrence, Local diagnosis, Neoplasms, Second Primary prevention & control, Physician's Role, Radiation Oncologists, Rectal Neoplasms diagnosis, Rectal Neoplasms radiotherapy
Abstract

Along with the surgeon, the gastroenterologist and the general practitioner, the radiation oncologist is involved in the follow-up of patients with rectal cancer treated by radiation. Post-treatment follow-up is recommended by major professional expert groups and consists of clinical examination, monitoring of carcinoembryonic antigen, colonoscopy and computed tomography of the abdomen and pelvis. Three recent large phase III randomized trials demonstrated a lack of survival benefit from intensive follow-up strategies in comparison with minimal follow-up. However, a follow-up program is not only important for the detection of an early disease relapse but it can be also used for the identification and the management of long-term toxicity and sequalae related to rectal cancer treatment., (Copyright © 2019 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.)

Published
2019
Full Text
View/download PDF

16. [Coexistence of a disc herniation and psoas hematoma revealed by L3 deficiency].

Author

Bemora JS, Labidi M, Marijon P, Bouazza S, Aldahak N, and Froelich S

Subjects
Anticoagulants adverse effects, Drug Overdose, Hematoma chemically induced, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Hematoma diagnostic imaging, Intervertebral Disc Displacement diagnostic imaging, Lumbar Vertebrae diagnostic imaging, Psoas Muscles diagnostic imaging, Radiculopathy etiology
Abstract

Radiculopathy is a constellation of symptoms secondary to a pathology affecting the nerve root, the most frequent cause of which is a herniated intervertebral disc. We report a case of a 58-year-old man under anticoagulant admitted to the neurosurgery department of Lariboisière hospital (Paris) for an L3 motor deficit that occurred progressively over a period of 24 hours with an L3-L4 disc herniation on the MRI. However, a psoas hematoma was also noted. Biological assessments revealed a hemostasis disorder. The final clinical diagnosis was a spontaneous hematoma caused by anticoagulant overdose. Psoas hematomas usually occur in patients with coagulopathy.

Published
2018

17. [Pineal metastasis of breast cancer: case report and review].

Author

Kanoun Belajouza S, Jaidane O, Labidi M, Kraiem C, and Bouaouina N

Subjects
Aged, Antineoplastic Agents, Hormonal therapeutic use, Brain Neoplasms therapy, Breast Neoplasms therapy, Carcinoma, Ductal, Breast therapy, Contrast Media, Female, Gadolinium, Humans, Lymph Node Excision, Magnetic Resonance Imaging, Mastectomy, Segmental, Radiotherapy, Adjuvant, Tamoxifen therapeutic use, Brain Neoplasms secondary, Breast Neoplasms pathology, Carcinoma, Ductal, Breast pathology, Carcinoma, Ductal, Breast secondary, Pineal Gland pathology
Abstract

Pineal metastases of solid tumors are rare. Primary cancer is generally absent at the diagnosis, for which a cerebral MRI is important. We report a case of pineal metastasis occurring in a 76-year-old woman treated for breast carcinoma in our department., (Copyright © 2014. Published by Elsevier SAS.)

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results